CAMBRIDGE, England--(BUSINESS WIRE)--Linguamatics Ltd, a leader in natural language processing (NLP) for the life science market, today announced that Pfizer has extended its strategic collaboration with Linguamatics to use the I2E knowledge discovery platform for text mining across their R&D organization. Pfizer researchers and other decision-makers will use I2E to discover and extract key facts and relationships from internal and external literature sources to support decision-making. Financial details of the agreement were not disclosed.
